Innovative Product Development Otsuka Pharmaceutical leverages advanced machine learning platforms and collaborates with biotech firms like iBio to accelerate growth in antibody and cardio-metabolic therapeutic areas, indicating a strong focus on innovative healthcare solutions that can benefit from specialized supplier or partnership services.
Behavioral Health Expansion With recent publications and initiatives such as the Trends in Behavioral Health Reference Guide and mental health equity grants, Otsuka demonstrates a commitment to mental health, creating opportunities for partnerships with mental health solution providers, research organizations, and community health programs.
Digital Engagement and Data The company's deployment of digital tools like interactive salary calculators and longitudinal mental health registries highlights their emphasis on data-driven healthcare, opening doors for technology vendors specializing in digital health solutions, patient engagement platforms, and health data analytics.
Regulatory and Policy Involvement Hosting policy events and collaborating on health financing and delivery system research indicates Otsuka's active engagement with health policy and advocacy efforts, suggesting potential collaborations with advocacy groups, policy consultants, and health economics experts.
Market Presence and Revenue With a substantial revenue range of one to ten billion dollars and a sizable employee base, Otsuka is a significant player in the pharmaceutical space, offering ample opportunities for suppliers, service providers, and partners specialized in drug development, clinical research, and healthcare commercialization.
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BOtsuka Pharmaceutical Companies (U.S.) uses 8 technology products and services including ggplot2, SiteCatalyst, CIM Technologies, and more. Explore Otsuka Pharmaceutical Companies (U.S.)'s tech stack below.
| Otsuka Pharmaceutical Companies (U.S.) Email Formats | Percentage |
| First.Last@otsuka-us.com | 77% |
| FirstL@otsuka-us.com | 20% |
| Last@otsuka-us.com | 2% |
| First.Middle@otsuka-us.com | 1% |
| First.Last@otsuka.com | 64% |
| FirstL@otsuka.com | 29% |
| Last@otsuka.com | 4% |
| FLast@otsuka.com | 2% |
| Last.First@otsuka.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees
There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America. Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) clinically develops and registers innovative healthcare products on a global basis.
Company Overview
Media & News
Funding & FinancialsOtsuka Pharmaceutical Companies (U.S.)'s revenue is estimated to be in the range of $1B$10B
Funding & FinancialsOtsuka Pharmaceutical Companies (U.S.)'s revenue is estimated to be in the range of $1B$10B
1-888-653-2347 
support@leadiq.com